TRiCares Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 67

Employees

  • Latest Deal Type
  • Debt

  • Latest Deal Amount
  • $23.4M

  • Investors
  • 9

TRiCares General Information

Description

Developer of a catheter-based valve replacement system designed for minimally invasive treatment of tricuspid valve regurgitation. The company's medical devices address tricuspid insufficiency through their anatomical conformation and their simplicity of use, enabling patients to avail of effective and lasting cures to the problem of tricuspid insufficiency.

Contact Information

Website
www.tricares.com
Formerly Known As
Mitricares
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Heisenbergbogen 2
  • 85609 Aschheim
  • Germany
+49 089
Primary Industry
Surgical Devices
Vertical(s)
Manufacturing, HealthTech, Life Sciences
Corporate Office
  • Heisenbergbogen 2
  • 85609 Aschheim
  • Germany
+49 089

TRiCares Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

TRiCares Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Debt - General 20-Jan-2026 $23.4M Completed Generating Revenue
5. Later Stage VC (Series D) 25-Jul-2024 Completed Generating Revenue
4. Later Stage VC (Series C) 15-Sep-2022 Completed Generating Revenue
3. Later Stage VC (Series B) 04-Jun-2018 Completed Generating Revenue
2. Seed Round 14-Sep-2015 $2.2M $2.2M Completed Startup
1. Angel (individual) Completed Startup
To view TRiCares’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

TRiCares Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a catheter-based valve replacement system designed for minimally invasive treatment of tricuspid valve regu
Surgical Devices
Aschheim, Germany
67 As of 2026

Amiens, France
 

Santa Cruz, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

TRiCares Competitors (21)

One of TRiCares’s 21 competitors is Open Stent Solution, a Venture Capital-Backed company based in Amiens, France.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Open Stent Solution Venture Capital-Backed Amiens, France
Emboline Venture Capital-Backed Santa Cruz, CA
Emblok Private Equity-Backed Tampa, FL
Revamp Medical Venture Capital-Backed Netania, Israel
HighLife Venture Capital-Backed Paris, France
You’re viewing 5 of 21 competitors. Get the full list »

TRiCares Patents

  • 124

    Total Documents Applications and Grants

  • Total Patents Families

  • 68

    Granted

  • 34

    Pending

  • Expiring in next 12 mo

TRiCares Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026153902-A1 Guide wire design and method Pending 14-Jan-2025
AU-2024408521-A1 Stent and replacement heart valve prosthesis with one cell design Pending 21-Dec-2023
EP-4574094-A1 Stent and replacement heart valve prosthesis with one cell design Inactive 21-Dec-2023
EP-4827665-A1 Stent and replacement heart valve prosthesis with one cell design Pending 21-Dec-2023
WO-2025132619-A1 Stent and replacement heart valve prosthesis with one cell design Inactive 21-Dec-2023 A61F2/2418
To view TRiCares’s complete patent history, request access »

TRiCares Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

TRiCares Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
415 Capital Venture Capital Minority
Bayern Kapital Venture Capital Minority
Andera Partners PE/Buyout Minority
BioMedPartners Venture Capital Minority
Crédit Mutuel Equity Growth/Expansion Minority
You’re viewing 5 of 9 investors. Get the full list »

Ready to get started?

Request a free trial

TRiCares FAQs

  • When was TRiCares founded?

    TRiCares was founded in 2013.

  • Where is TRiCares headquartered?

    TRiCares is headquartered in Aschheim, Germany.

  • What is the size of TRiCares?

    TRiCares has 67 total employees.

  • What industry is TRiCares in?

    TRiCares’s primary industry is Surgical Devices.

  • Is TRiCares a private or public company?

    TRiCares is a Private company.

  • What is TRiCares’s current revenue?

    The current revenue for TRiCares is .

  • How much funding has TRiCares raised over time?

    TRiCares has raised $153M.

  • Who are TRiCares’s investors?

    415 Capital, Bayern Kapital, Andera Partners, BioMedPartners, and Crédit Mutuel Equity are 5 of 9 investors who have invested in TRiCares.

  • Who are TRiCares’s competitors?

    Open Stent Solution, Emboline, Emblok, Revamp Medical, and HighLife are some of the 21 competitors of TRiCares.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process